| |
| |
|
| Insider
Information: |
Siegall Clay B |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,088,246 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$158,512,956 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,088,246 |
|
|
| Total
Value |
$158,512,956 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -49.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
President & CEO, Direc... |
2022-05-12 |
666,060 |
2016-09-10 |
0 |
Premium* |
|
|
Alder Biopharmaceuticals Inc |
ALDR |
Director |
2019-10-22 |
0 |
2014-05-13 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2020-08-10 |
2,550 |
2016-06-09 |
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
419,636 |
2023-10-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2021-04-08 |
4 |
AS |
$144.40 |
$2,431,816 |
D/D |
(16,751) |
715,209 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2021-04-09 |
4 |
AS |
$141.42 |
$1,788,924 |
D/D |
(12,602) |
715,209 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2021-05-06 |
4 |
AS |
$134.29 |
$3,961,824 |
D/D |
(29,353) |
715,209 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2021-06-03 |
4 |
AS |
$142.07 |
$4,241,801 |
D/D |
(29,353) |
715,209 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2021-07-01 |
4 |
AS |
$156.94 |
$2,222,376 |
D/D |
(14,085) |
715,209 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2021-07-02 |
4 |
AS |
$155.70 |
$2,387,233 |
D/D |
(15,268) |
715,209 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2021-08-05 |
4 |
AS |
$162.02 |
$3,842,086 |
D/D |
(23,560) |
715,209 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2021-08-06 |
4 |
AS |
$159.26 |
$925,134 |
D/D |
(5,793) |
715,209 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2021-08-16 |
4 |
AS |
$154.55 |
$431,051 |
D/D |
(2,789) |
712,420 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2021-08-31 |
4 |
AS |
$167.52 |
$2,404,015 |
D/D |
(14,351) |
668,458 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2021-12-07 |
4 |
AS |
$146.54 |
$6,756,632 |
D/D |
(45,449) |
669,172 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2021-12-20 |
4 |
AS |
$149.85 |
$183,866 |
D/D |
(1,227) |
667,945 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2022-01-07 |
4 |
AS |
$143.91 |
$2,466,743 |
D/D |
(17,044) |
667,945 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2022-02-07 |
4 |
AS |
$137.29 |
$2,385,566 |
D/D |
(17,043) |
667,945 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2022-03-07 |
4 |
AS |
$132.72 |
$2,289,655 |
D/D |
(17,043) |
667,945 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2022-04-07 |
4 |
AS |
$151.42 |
$2,628,610 |
D/D |
(17,043) |
667,945 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2022-04-20 |
4 |
AS |
$144.32 |
$272,041 |
D/D |
(1,885) |
666,060 |
0 |
- |
|
| SGEN |
Seagen Inc |
President & CEO |
• • – |
2022-05-12 |
4 |
AS |
$125.39 |
$2,142,117 |
D/D |
(17,043) |
666,060 |
0 |
- |
|
| IMNM |
Immunome Inc. |
President and CEO |
• • – |
2023-10-02 |
4 |
B |
$5.91 |
$999,996 |
D/D |
169,204 |
319,636 |
2.81 |
% |
|
| IMNM |
Immunome Inc. |
President and CEO |
• • – |
2024-05-20 |
4 |
B |
$13.91 |
$1,106,524 |
D/D |
79,566 |
399,202 |
0.01 |
% |
|
| IMNM |
Immunome Inc. |
President and CEO |
• • – |
2024-05-21 |
4 |
B |
$13.78 |
$281,548 |
D/D |
20,434 |
419,636 |
0.01 |
% |
|
| ALDR |
Alder Biopharmaceuticals ... |
Director |
– • – |
2019-10-22 |
4 |
D |
$18.00 |
$570,852 |
D/D |
(31,714) |
0 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2020-04-21 |
4 |
D |
$139.92 |
$422,969 |
D/D |
(3,023) |
768,339 |
0 |
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2005-07-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,286,500 |
|
- |
|
| SGEN |
Seagen Inc |
President and CEO |
• • – |
2011-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,833 |
945,667 |
0 |
- |
|
376 Records found
|
|
Page 7 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
